Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BBOT · NASDAQ · Pharmaceutical Preparations
$1.81−0.135 (−6.96%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
Bridgebio Oncology Therapeutics (BBOT) · oqro.io/stocks/BBOT · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Planned sale · Planned for Nov 18, 2026 · Notice filed Nov 18, 2026
Officer filed to sell about $3.6K of BBOT stockSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 17, 2026
Officer sold ~$185 of BBOT shares in the open marketSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 13, 2026
Deerfield Management Company, L.P. cut its BBOT stake below 5% (3.9%)SourcePlanned sale · Planned for Nov 13, 2026 · Notice filed Nov 13, 2026
Officer filed to sell about $183 of BBOT stockSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Paradigm Biocapital Advisors LP disclosed a reduced position in BBOT for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Paradigm Biocapital Advisors LP disclosed an increased position in BBOT for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deerfield Management Company, L.P. disclosed a new position in BBOT for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Paradigm Biocapital Advisors LP disclosed a new position in BBOT for Q3 2025Source